DK175040B1 - Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme - Google Patents

Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme Download PDF

Info

Publication number
DK175040B1
DK175040B1 DK198704966A DK496687A DK175040B1 DK 175040 B1 DK175040 B1 DK 175040B1 DK 198704966 A DK198704966 A DK 198704966A DK 496687 A DK496687 A DK 496687A DK 175040 B1 DK175040 B1 DK 175040B1
Authority
DK
Denmark
Prior art keywords
medetomidine
treatment
anxiety disorders
drug
preparation
Prior art date
Application number
DK198704966A
Other languages
Danish (da)
English (en)
Other versions
DK496687D0 (da
DK496687A (da
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of DK496687D0 publication Critical patent/DK496687D0/da
Publication of DK496687A publication Critical patent/DK496687A/da
Application granted granted Critical
Publication of DK175040B1 publication Critical patent/DK175040B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK198704966A 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme DK175040B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.
FI864570 1986-11-11

Publications (3)

Publication Number Publication Date
DK496687D0 DK496687D0 (da) 1987-09-22
DK496687A DK496687A (da) 1988-05-12
DK175040B1 true DK175040B1 (da) 2004-05-10

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704966A DK175040B1 (da) 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme

Country Status (12)

Country Link
US (1) US4783477A (de)
EP (1) EP0270267B1 (de)
JP (1) JPS63135330A (de)
AT (1) ATE88343T1 (de)
AU (1) AU587144B2 (de)
DE (1) DE3785549T2 (de)
DK (1) DK175040B1 (de)
ES (1) ES2054687T3 (de)
FI (1) FI864570A0 (de)
HU (1) HU201472B (de)
IE (1) IE60121B1 (de)
ZA (1) ZA878055B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
GB9111732D0 (en) 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
DE69823868T2 (de) * 1997-12-04 2005-04-21 Allergan Inc Substituierte imidazole derivate mit agonistischähnlicher wirkung auf die alpha 2b oder 2b/2c adrenergischen rezeptoren
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
BR112015008459B1 (pt) * 2012-10-15 2020-11-10 Orion Corporation uso de dexmedetomidina, medetomidina ou um sal farmaceuticamente aceitável destas para a fabricação de um medicamento para aliviar a aversão ao ruído em um animal
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
TWI629066B (zh) 2013-10-07 2018-07-11 帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
RU2018105761A (ru) 2013-10-07 2019-02-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
KR20240096833A (ko) * 2016-12-13 2024-06-26 오리온 코포레이션 개에서의 분리 불안의 치료에 사용하기 위한 덱스메데토미딘 또는 메데토미딘

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
DK496687D0 (da) 1987-09-22
EP0270267A2 (de) 1988-06-08
FI864570A0 (fi) 1986-11-11
DE3785549T2 (de) 1993-09-09
ES2054687T3 (es) 1994-08-16
US4783477A (en) 1988-11-08
AU7826987A (en) 1988-05-12
AU587144B2 (en) 1989-08-03
HUT45399A (en) 1988-07-28
HU201472B (en) 1990-11-28
ZA878055B (en) 1988-04-26
DE3785549D1 (de) 1993-05-27
EP0270267B1 (de) 1993-04-21
EP0270267A3 (en) 1990-07-04
IE873015L (en) 1988-05-11
IE60121B1 (en) 1994-06-01
ATE88343T1 (de) 1993-05-15
JPS63135330A (ja) 1988-06-07
DK496687A (da) 1988-05-12

Similar Documents

Publication Publication Date Title
DK175040B1 (da) Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme
CA2205134C (en) A method for treating vascular headaches
McNamara et al. Some behavioural and neurochemical aspects of subacute (±) 3, 4-methylenedioxymethamphetamine administration in rats
Hilliker et al. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline
Fukumoto et al. Effect of flavour components in lemon essential oil on physical or psychological stress
JPH0643299B2 (ja) 薬剤療法
LEVIN et al. Relationships between arginine and glucose in the induction of insulin secretion from the isolated, perfused rat pancreas
Urban et al. Effect of the anxiolytic drug buspirone on prolactin and corticosterone secretion in stressed and unstressed rats
Petty et al. Learned helplessness sensitizes hippocampal norepinephrine to mild restress
Berlan et al. Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.
Mannelli et al. A study on human adrenal secretion. Measurement of epinephrine, norepinephrine, dopamine and cortisol in peripheral and adrenal venous blood under surgical stress
LORENZEN et al. Effect of drugs related to α-ethyltryptamine on stress-induced ACTH secretion in the dog
Thomas et al. Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex
Kłodzińska et al. Anticonflict effect of the glycine B receptor partial agonist, d-cycloserine, in rats. Pharmacological analysis
Østergaard et al. Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery
Lees Levodopa substitution: the gold standard
Roy-Byrne et al. Suppression of norepinephrine appearance rate in plasma by diazepam in humans
Kahan et al. Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional α‐and β‐adrenoceptors in vivo
US4380550A (en) Guanfacine in treating opiate addiction
Barney et al. Effects of serotonin and L-5-hydroxytryptophan on plasma renin activity in rats
CN103501609A (zh) 用于偏头痛的治疗
Leipheimer et al. Influence of estradiol and progesterone on pulsatile LH secretion in 8-day ovariectomized rats
Del Bianco et al. Human 5-hydroxytryptamine venomotor receptors
Prange Jr et al. Drug responses in hyperthyroid children suggesting an endogenous false transmitter
Thomas et al. Regionally specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis

Legal Events

Date Code Title Description
PUP Patent expired